The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...

Once-weekly semaglutide shows significant reduction in knee osteoarthritis pain and body weight in adults with obesity, a ...

Chronic health conditions and decisions to delay pregnancies mean state may have to rely on methods like immigration to grow.

A joint study by the University of Melbourne and RMIT University titled 'the fattening speed' explored the link between high ...

A study [1] published in the journal Science last week examines the impact of sugar exposure in the first 1,000 days after ...

The majority of strokes could be prevented, according to new guidelines aimed at helping people and their doctors do just ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

The national use of weight loss drugs like Ozempic and Wegovy more than doubled as bariatric surgery frequency dropped by ...

THURSDAY, Nov. 7, 2024 (HealthDay News) -- Expanding access to obesity medications such as glucagon-like peptide 1 (GLP-1) receptor agonists and dual gastric inhibitory polypeptide and GLP-1 receptor ...

Obesity caused by a lifestyle of moving less and eating more is a prime factor contributing to Type 2 diabetes. Is the answer new weight loss drugs?